search
Back to results

Exercise to Treat Frailty and Decreased Physical Function in Transplant Candidates

Primary Purpose

Kidney Transplant, Frailty

Status
Suspended
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Exercise Program
Sponsored by
Mayo Clinic
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Kidney Transplant

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Aged 18 years or older
  • Consenting to research
  • CKD (stages 1-5)
  • An SPPB score ≤10 or considered frail or pre-frail by FP

Exclusion Criteria:

  • Younger than 18 years
  • Patients listed for heart or lung transplants
  • Terminal illness with a prognosis of less than 6 months
  • Significant comorbidities that limit rehabilitation potential including pulmonary disease requiring continuous oxygen supplementation, active angina, critical aortic sclerosis, decompensated heart failure, or known ventricular arrhythmia.
  • Kidney transplant candidates without cardiac clearance for transplant
  • An SPPB score >10 or not considered frail or pre-frail by FP
  • Non-English speaker without availability of adequate interpreter services (safety concern)
  • Failure to pass submaximal exercise test

Sites / Locations

  • Mayo Clinic

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Exercise Program

Arm Description

All participants will attend a 16-session exercise program based on pulmonary rehabilitation and will complete questionnaires and frailty testing.

Outcomes

Primary Outcome Measures

Change in Frailty Status
Frailty will be determined by Frailty Phenotype (FP) or Short Physical Performance Battery (SPPB) scores. FP is determined by the presence of 3 or more of the following: slowness (measured by gait speed), exhaustion (measured with the CES-D), weakness (measured by hand grip strength), low physical activity level (measured with the MLTPAQ and activity monitoring), and wasting (measured through self-report or by tracking changes in weight). The SPPB consists of a gait speed test, balance testing, and repeated chair stands. A score less than or equal to 10 will be considered frail.

Secondary Outcome Measures

Change in Grip Strength
Hand grip strength will be measured using a hand-held dynamometer. Frailty is characterized as the lowest 20% by gender and body mass index.
Change in Gait Speed
Gait speed will be measured over a distance of 15 feet at the patient's self-selected walking speed. Frailty is characterized as the slowest 20% by gender and height. Results will be prorated for 4 meters for the SPPB score.
Change in Exhaustion
Patients will self-report their level of exhaustion using the Center for Epidemiologic Studies Depression Scale (CES-D) which consists of a 4-point scale. Items on the CES-D are scored from minimum to maximum values (1 point to 4 points) which are indicated on the CES-D as "rarely or none of the time," "some or a little of the time," "occasionally or a moderate amount of time," "most or all of the time," respectively. A higher number of points indicates a worse outcome.
Change in Activity
Energy expenditure will be measured using an activity monitor worn on the wrist for 5-7 days. Low activity is defined as activity in the lowest 20% (<383 Kcals/week for men or <270 Kcals/week for women). Patients will also self-report their activity level using the MLTPAQ.
Wasting
Wasting is defined as a decrease in lean body mass or unintentional weight loss of 10 or more pounds in one year.
Change in SPPB Score
The SPPB consists of a gait speed test, repeated chair stands, and balance testing. Lower scores indicate decreased physical function.
Change in Quality of Life
Health-related quality of life will be measured using the KDQOL-SF.
Post-Transplant Outcomes
The relationship between exercise, frailty status, and post-transplant outcomes will be examined for patients who receive a transplant within 1 year of enrolling in this study. The various outcome measures will be aggregated to indicate mortality rate up to one year post-transplant.

Full Information

First Posted
May 3, 2018
Last Updated
March 9, 2023
Sponsor
Mayo Clinic
search

1. Study Identification

Unique Protocol Identification Number
NCT03535584
Brief Title
Exercise to Treat Frailty and Decreased Physical Function in Transplant Candidates
Official Title
Exercise as an Intervention to Treat Frailty and Decreased Physical Function in Kidney Transplant Candidates
Study Type
Interventional

2. Study Status

Record Verification Date
March 2023
Overall Recruitment Status
Suspended
Why Stopped
Due to Covid19 pandemic at this time we are on pause
Study Start Date
June 12, 2018 (Actual)
Primary Completion Date
December 31, 2023 (Anticipated)
Study Completion Date
December 31, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Mayo Clinic

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Frailty is a condition characterized by slowness, weakness, low physical activity, wasting, and exhaustion. Frailty increases the risk for adverse outcomes following transplant such as increased length of stay in the hospital, mortality, or graft function. No interventions for frailty are known for patients with renal disease, but exercise programs like pulmonary rehabilitation have been effective in improving frailty in patients with other diseases, such as lung disease. The goal of this study is to test whether exercise will also improve frailty among patients who are waiting for a kidney transplant and who are considered frail or pre-frail.
Detailed Description
RECRUITMENT: This study will be conducted at Mayo Clinic in Rochester, MN. Patients over 18 who have chronic kidney disease will be approached for recruitment. Interested patients will go through the informed consent process and, if frailty testing was not completed within the two weeks prior to consent, patients will complete frailty testing. If patients are considered frail or pre-frail, they will be enrolled in the study. FRAILTY TESTING: Participants will complete the FP, Short Physical Performance Battery (SPPB) and other frailty testing at the beginning of the study, 4 weeks after beginning the intervention, and 8 weeks after beginning the intervention. Frailty testing will include a hand grip strength test, a gait speed test over 15 feet, repeated chair stands, balance testing, and a body composition scan. Participants will also be asked to wear an activity monitor for 5-7 days at each testing point and to complete a set of questionnaires. Height, weight, BMI, skeletal muscle mass, percent body fat, and segmental lean mass will be recorded. Participants with a pacemaker, an implantable cardioverter-defibrillator (ICD), or an automated ICD (AICD) will not be able to complete. At enrollment, participants 55 and older will undergo a submaximal exercise test to rule out significant undiagnosed cardiopulmonary disease (standard entrance criteria for pulmonary rehabilitation). INTERVENTION: Participants will be asked to complete 2 1-hour exercise sessions per week for 8 weeks (16 total sessions) under the supervision of a licensed respiratory therapist in Rochester, MN on non-dialysis days unless the participant is on daily or near-daily dialysis (e.g. home hemodialysis or peritoneal dialysis). . The exercise sessions will be based on pulmonary rehabilitation and will follow guidelines established by the American Thoracic Society. Exercise sessions will include endurance (treadmill or cycle ergometer), strength, and flexibility training and will be tailored to individual participants.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Kidney Transplant, Frailty

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
50 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Exercise Program
Arm Type
Experimental
Arm Description
All participants will attend a 16-session exercise program based on pulmonary rehabilitation and will complete questionnaires and frailty testing.
Intervention Type
Behavioral
Intervention Name(s)
Exercise Program
Intervention Description
Participants will be asked to complete 2 1-hour exercise sessions per week for 8 weeks (16 total sessions) under the supervision of a licensed respiratory therapist on non-dialysis days. The exercise program will be based on pulmonary rehabilitation and will follow guidelines established by the American Thoracic Society. Exercise sessions will include endurance (treadmill or cycle ergometer), strength (weight resistance), and flexibility training. Exercise sessions will be tailored to individual participants, and participant safety will be monitored during each session.
Primary Outcome Measure Information:
Title
Change in Frailty Status
Description
Frailty will be determined by Frailty Phenotype (FP) or Short Physical Performance Battery (SPPB) scores. FP is determined by the presence of 3 or more of the following: slowness (measured by gait speed), exhaustion (measured with the CES-D), weakness (measured by hand grip strength), low physical activity level (measured with the MLTPAQ and activity monitoring), and wasting (measured through self-report or by tracking changes in weight). The SPPB consists of a gait speed test, balance testing, and repeated chair stands. A score less than or equal to 10 will be considered frail.
Time Frame
2 Months
Secondary Outcome Measure Information:
Title
Change in Grip Strength
Description
Hand grip strength will be measured using a hand-held dynamometer. Frailty is characterized as the lowest 20% by gender and body mass index.
Time Frame
2 Months
Title
Change in Gait Speed
Description
Gait speed will be measured over a distance of 15 feet at the patient's self-selected walking speed. Frailty is characterized as the slowest 20% by gender and height. Results will be prorated for 4 meters for the SPPB score.
Time Frame
2 Months
Title
Change in Exhaustion
Description
Patients will self-report their level of exhaustion using the Center for Epidemiologic Studies Depression Scale (CES-D) which consists of a 4-point scale. Items on the CES-D are scored from minimum to maximum values (1 point to 4 points) which are indicated on the CES-D as "rarely or none of the time," "some or a little of the time," "occasionally or a moderate amount of time," "most or all of the time," respectively. A higher number of points indicates a worse outcome.
Time Frame
2 Months
Title
Change in Activity
Description
Energy expenditure will be measured using an activity monitor worn on the wrist for 5-7 days. Low activity is defined as activity in the lowest 20% (<383 Kcals/week for men or <270 Kcals/week for women). Patients will also self-report their activity level using the MLTPAQ.
Time Frame
2 Months
Title
Wasting
Description
Wasting is defined as a decrease in lean body mass or unintentional weight loss of 10 or more pounds in one year.
Time Frame
2 Months
Title
Change in SPPB Score
Description
The SPPB consists of a gait speed test, repeated chair stands, and balance testing. Lower scores indicate decreased physical function.
Time Frame
2 Months
Title
Change in Quality of Life
Description
Health-related quality of life will be measured using the KDQOL-SF.
Time Frame
2 Months
Title
Post-Transplant Outcomes
Description
The relationship between exercise, frailty status, and post-transplant outcomes will be examined for patients who receive a transplant within 1 year of enrolling in this study. The various outcome measures will be aggregated to indicate mortality rate up to one year post-transplant.
Time Frame
1 Year

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Aged 18 years or older Consenting to research CKD (stages 1-5) An SPPB score ≤10 or considered frail or pre-frail by FP Exclusion Criteria: Younger than 18 years Patients listed for heart or lung transplants Terminal illness with a prognosis of less than 6 months Significant comorbidities that limit rehabilitation potential including pulmonary disease requiring continuous oxygen supplementation, active angina, critical aortic sclerosis, decompensated heart failure, or known ventricular arrhythmia. Kidney transplant candidates without cardiac clearance for transplant An SPPB score >10 or not considered frail or pre-frail by FP Non-English speaker without availability of adequate interpreter services (safety concern) Failure to pass submaximal exercise test
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Cassie C Kennedy, MD
Organizational Affiliation
Mayo Clinic
Official's Role
Principal Investigator
Facility Information:
Facility Name
Mayo Clinic
City
Rochester
State/Province
Minnesota
ZIP/Postal Code
55902
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
32573816
Citation
Lorenz EC, Hickson LJ, Weatherly RM, Thompson KL, Walker HA, Rasmussen JM, Stewart TL, Garrett JK, Amer H, Kennedy CC. Protocolized exercise improves frailty parameters and lower extremity impairment: A promising prehabilitation strategy for kidney transplant candidates. Clin Transplant. 2020 Sep;34(9):e14017. doi: 10.1111/ctr.14017. Epub 2020 Jul 24.
Results Reference
derived
Links:
URL
https://www.mayo.edu/research/clinical-trials
Description
Mayo Clinic Clinical Trials

Learn more about this trial

Exercise to Treat Frailty and Decreased Physical Function in Transplant Candidates

We'll reach out to this number within 24 hrs